References
- Chan, K. H., Farouji, I., Slim, J., Shaaban, H. S., & Guron, G.
Tranexamic acid: A potential treatment option for coronavirus disease
2019. Journal of Global Infectious Diseases, 2020, 12(3), 160.
- ASAKURA, Hidesaku; OGAWA, Haruhiko. Potential of heparin and
nafamostat combination therapy for COVID‐19. Journal of Thrombosis and
Haemostasis, 2020, 18.6: 1521-1522.
- BARKER, Andrew B.; WAGENER, Brant M. An Ounce of Prevention May
Prevent Hospitalization. Physiological Reviews, 2020, 100.3:
1347-1348.
- PARTHVI, Rukma; MEHRA, Sunil. Risk of pulmonary embolism due to
tranexamic acid: a case study. American journal of therapeutics, 2018,
25.4: e512-e514.
- IJAOPO, Ezekiel Oluwasayo; IJAOPO, Ruth Oluwasolape; ADJEI, Sampson.
Bilateral pulmonary embolism while receiving tranexamic acid: a case
report. Journal of medical case reports, 2020, 14.1: 1-6.
- OGAWA, Haruhiko; ASAKURA, Hidesaku. Consideration of tranexamic acid
administration to COVID-19 patients. Physiological reviews, 2020,
100.4: 1595-1596.
- HELMS, J., Clere-Jehl, R., Bianchini, E., Le Borgne, P., Burban, M.,
Zobairi, F, et al. Thrombomodulin favors leukocyte microvesicle
fibrinolytic activity, reduces NETosis and prevents septic
shock-induced coagulopathy in rats. Annals of intensive care, 2017,
7.1: 1-10.
- COCCHERI, Sergio. COVID-19: The crucial role of blood coagulation and
fibrinolysis. Internal and emergency medicine, 2020, 15.8: 1369-1373.
- Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are
associated with poor prognosis in patients with novel coronavirus
pneumonia. J Thromb Hemost, 2020;18(4):844–7.
- Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous
thromboembolism in patients with severe novel coronavirus pneumonia. J
Thromb Haemost 2020:1421–4.
- Bangalore S, Sharma A, Slotwiner A, Yatskar L, Harari R, Shah B, et
al. ST-segment elevation in patients with Covid-19 - a case series. N
Eng J Med 2020.
- Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel
AS, et al. Endothelial cell infection and endothelitis in COVID-19.
Lancet 2020;395(10234):1417–8.
- BESTER, Janette; PRETORIUS, Etheresia. Effects of IL-1β, IL-6 and IL-8
on erythrocytes, platelets and clot viscoelasticity. Scientific
reports, 2016, 6.1: 1-10.
- Tucker T, Idell S. Plasminogen‐plasmin system in the pathogenesis and
treatment of lung and pleural injury. Semin Thromb
Hemost. 2013; 39: 373‐ 381.
- Wu Y, Wang T, Guo C, et al. Plasminogen improves lung lesions and
hypoxemia in patients with COVID‐19. QJM. 2020;113(8):539‐545.
- Danzi GB, Loffi M, Galeazzi G, Gherbesi E. Acute pulmonary embolism
and COVID‐19 pneumonia: a random association? Eur Heart
J. 2020;41(19):1858.